MedTrace Logo

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

NCT02494284 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2017-02-23

No results posted yet for this study

Summary

The purpose of this study is to compare short-term (6-month Dual Anti Platelet Therapy(DAPT) followed by clopidogrel monotherapy) vs. standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy) on clinically relevant bleeding complications (Bleeding Academic Research Consortium(BARC) type 2, 3, or 5)31 in patients after zotarolimus-eluting stent implantation.

Conditions

Interventions

DRUG

Clopidogrel

6-month DAPT followed by clopidogrel monotherapy

DRUG

Aspirin plus clopidogrel

standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy)

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Medtronic

    collaborator INDUSTRY

  • Chong Kun Dang Pharmaceutical Corp.

    collaborator INDUSTRY

  • CHEOL WHAN LEE, M.D., Ph.D

    lead OTHER

Principal Investigators

  • Seung-Jung Park, MD · Asan Medical Center

  • Cheol-Whan Lee, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-22
Primary Completion
2017-02-13
Completion
2017-02-13

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02494284 on ClinicalTrials.gov